<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions</funding><funding>Technology Innovation Commission</funding><pagination>1350</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9312019</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>(1) Background: With unknown causes and no effective treatment available, Alzheimer's disease (AD) places enormous pressure on families and society. Our previous study had shown that Ebselen at a high concentration (10.94 μM) improved the cognition of triple-transgenic AD (3×Tg-AD) mice and alleviated the related pathological indicators but showed toxicity to the mice. Here, we dedicated to study the therapeutic effect and molecular mechanism of Ebselen at a much lower concentration on 3×Tg-AD mice. (2) Methods: Various behavioral experiments were applied to detect the behavioral ability of mice. Western blot, thioflavin T staining and a transmission electron microscope were used to evaluate the pathology of AD mice. The mitochondrial membrane potential and respiration were assessed with t</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Ebselen Interferes with Alzheimer's Disease by Regulating Mitochondrial Function.</pubmed_title><pmcid>PMC9312019</pmcid><funding_grant_id>2021SHIBS0003</funding_grant_id><funding_grant_id>JCYJ20200109110001818</funding_grant_id><funding_grant_id>JCYJ20180507182417779</funding_grant_id><pubmed_authors>Xiong Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Le L</pubmed_authors><pubmed_authors>Lian J</pubmed_authors><pubmed_authors>Peng F</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Shi Q</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Du X</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Wu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ebselen Interferes with Alzheimer's Disease by Regulating Mitochondrial Function.</name><description>(1) Background: With unknown causes and no effective treatment available, Alzheimer's disease (AD) places enormous pressure on families and society. Our previous study had shown that Ebselen at a high concentration (10.94 μM) improved the cognition of triple-transgenic AD (3×Tg-AD) mice and alleviated the related pathological indicators but showed toxicity to the mice. Here, we dedicated to study the therapeutic effect and molecular mechanism of Ebselen at a much lower concentration on 3×Tg-AD mice. (2) Methods: Various behavioral experiments were applied to detect the behavioral ability of mice. Western blot, thioflavin T staining and a transmission electron microscope were used to evaluate the pathology of AD mice. The mitochondrial membrane potential and respiration were assessed with t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-05-31T22:26:06.06Z</modification><creation>2022-08-05T06:28:16.804Z</creation></dates><accession>S-EPMC9312019</accession><cross_references><pubmed>35883841</pubmed><doi>10.3390/antiox11071350</doi></cross_references></HashMap>